SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manfredhasler who wrote (14698)9/17/2000 10:20:24 AM
From: Robert K.  Read Replies (1) of 17367
 
So manfred, can you defend the FDA's decision to over-ride
standards for the HIV drug? How is that any different from BPI? Subpart E (which bpi has) gives the FDA broad discretionary authority. Apparently, the FDA has thusfar chosen to withhold decision on bpi, but yet they can really move things along for that HIV drug.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext